No Data
THE MILESTONE GROUP ANNOUNCES ACQUISITION OF AXIS DELRAY BEACH APARTMENTS IN DELRAY BEACH, FLORIDA
DELRAY BEACH, Fla., June 27, 2024 /PRNewswire/ -- The Milestone Group (Milestone) announces its acquisition of the Axis Delray Beach Apartments, a 488-unit, garden-style multifamily community located
TD Cowen Maintains Milestone Pharmaceuticals(MIST.US) With Buy Rating, Maintains Target Price $9
TD Cowen analyst Ritu Baral maintains $Milestone Pharmaceuticals(MIST.US)$ with a buy rating, and maintains the target price at $9.According to TipRanks data, the analyst has a success rate of 45.7% a
Piper Sandler Maintains Milestone Pharmaceuticals(MIST.US) With Buy Rating, Maintains Target Price $5
Piper Sandler analyst Edward Tenthoff maintains $Milestone Pharmaceuticals(MIST.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate
Milestone Pharmaceuticals to Host KOL Event for Investors "Learnings From the Field: Expert Perspectives on PSVT in the Community Setting" on June 20, 2024
MONTREAL and CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovat
It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put Under The Microscope
Milestone Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
MONTREAL and CHARLOTTE, N.C., May 31, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (NASDAQ:MIST) today announced that members of its management team will participate in the Jefferies Global Healthcare